Company Quick10K Filing
TPG Real Estate Finance Trust
10-Q 2021-03-31 Filed 2021-05-04
10-K 2020-12-31 Filed 2021-02-24
10-Q 2020-09-30 Filed 2020-11-04
10-Q 2020-06-30 Filed 2020-07-29
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-10-28
10-Q 2019-06-30 Filed 2019-07-29
10-Q 2019-03-31 Filed 2019-04-29
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-02-26
10-Q 2017-09-30 Filed 2017-11-06
10-Q 2017-06-30 Filed 2017-08-24
8-K 2020-11-04
8-K 2020-09-15
8-K 2020-07-29
8-K 2020-07-13
8-K 2020-06-30
8-K 2020-06-17
8-K 2020-06-03
8-K 2020-05-29
8-K 2020-05-11
8-K 2020-03-18
8-K 2020-02-18
8-K 2019-10-28
8-K 2019-07-29
8-K 2019-05-21
8-K 2019-04-29
8-K 2019-03-14
8-K 2019-03-07
8-K 2019-02-25
8-K 2018-11-29
8-K 2018-11-05
8-K 2018-08-07
8-K 2018-08-06
8-K 2018-06-15
8-K 2018-05-23
8-K 2018-05-07
8-K 2018-02-26
8-K 2018-02-14

TPG Real Estate Finance Trust Financials

TRTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2016576754346415670100
Accounts Receivable0000000000
Inventory
PP&E
Assets2,5873,0433,3553,8424,1234,3024,5275,1195,8255,863
Accounts Payable
Long-Term Debt2,2011,537
Liabilities1,5831,8352,1542,6492,9312,9733,2003,6764,3604,397
Stockholders' Equity1,0041,2081,2011,1931,1921,3291,3271,4441,4651,466
Income Statement ($MM)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A111111122
Tax-0000-00000
Net Income252125252627283233
Cash Flow ($MM)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating15242329262735
Cash Investing-590-301-481-315-590-6786
Cash Financing440287456255579666-12